Viberzi
My Prescription
Payment
Select pharmacy
$1,702.23
Print or send this coupon to your phone
AlbertsonsPowered byAbout Viberzi
Drug Details
Viberzi (eluxadoline) is a prescribed medication specifically designed to treat irritable bowel syndrome with diarrhea (IBS-D). It alleviates abdominal discomfort and diarrhea by acting on opioid receptors in the intestines, effectively slowing down gut movement. This action helps reduce symptoms such as belly pain and diarrhea, providing relief for individuals with IBS-D. Always consult your healthcare provider before starting any new medication to ensure it is appropriate for your condition.
Price history for Viberzi
60 Tablets, 100MG
Average retail price for Viberzi
Average SaveHealth price for Viberzi
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.
Viberzi dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 75MG | 60 Tablets | $1,703.37 | $28.39 |
| 100MG | 60 Tablets | $1,702.43 | $28.37 |
Viberzi FAQs
Viberzi is considered a narcotic because it acts on the opioid receptors in the body. It is classified as a Schedule IV controlled substance due to its potential for abuse and dependence, similar to other narcotics.
Viberzi and Imodium are not the same. Viberzi (eluxadoline) is a prescription medication used to treat irritable bowel syndrome with diarrhea (IBS-D), while Imodium (loperamide) is an over-the-counter medication used to treat diarrhea by slowing down gut movement. They work differently and are used for different purposes.
Viberzi works by targeting the digestive system, specifically the gut. It acts as a mu-opioid receptor agonist and a delta-opioid receptor antagonist. This dual action helps to reduce bowel contractions and slow down the movement of the intestines, which can alleviate symptoms such as diarrhea and abdominal pain associated with irritable bowel syndrome with diarrhea (IBS-D).
Viberzi (eluxadoline) is not considered habit-forming. It is a medication used to treat irritable bowel syndrome with diarrhea (IBS-D) and does not have addictive properties. However, it is important for patients to use it as prescribed by their healthcare provider.
Viberzi (eluxadoline) is classified as a controlled substance because it acts on the opioid receptors in the body. This action has the potential for abuse and dependence, similar to other opioid medications. Therefore, it is regulated to prevent misuse and ensure safe prescribing practices.